Is a longer time interval between recombinant human deoxyribonuclease (dornase alfa) and chest physiotherapy better?: A multi-center, randomized crossover trial-Reference-Cited by-同舟云学术

Is a longer time interval between recombinant human deoxyribonuclease (dornase alfa) and chest physiotherapy better?: A multi-center, randomized crossover trial

Published:2007 Issue:12 Volume:42 Page:1110-1116
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr. Pulmonol.

Author:

Wilson Christine J.,Robbins Lisel J.,Murphy Jennifer M.,Chang Anne B.

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference28 articles.

1. , . Recombinant human dexyribonuclease for cystic fibrosis. Cochrane Database of Systematic Reviews 2003, Issue 3. art No: CD001127. DOI: 10.1002/14651858.CD001127.

2. DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: Influence of treatment with dornase alpha

3. Roche Pulmozyme® Inhalation Solution (dornase alfa). TGA Approved Product information eMIMS: last amendment 10/08/2005. 2005.

4. Quality of life in patients with cystic fibrosis

5. ADHD: the facts

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalising airway clearance in chronic suppurative lung diseases: a scoping review;ERJ Open Research;2023-05

2. Dornase alfa for cystic fibrosis;Cochrane Database of Systematic Reviews;2021-03-18

3. Timing of dornase alfa inhalation for cystic fibrosis;Cochrane Database of Systematic Reviews;2021-03-09

4. Exercise and Cystic Fibrosis;Physical Exercise for Human Health;2020

5. Timing of dornase alfa inhalation for cystic fibrosis;Cochrane Database of Systematic Reviews;2018-11-12